11/12
12:09 pm
mgtx
Senate Punts On Health Insurance Subsidies To End Shutdown [Forbes]
Medium
Report
Senate Punts On Health Insurance Subsidies To End Shutdown [Forbes]
11/11
12:49 pm
mgtx
MeiraGTx (NASDAQ:MGTX) had its price target raised by analysts at Piper Sandler from $28.00 to $30.00. They now have an "overweight" rating on the stock.
Low
Report
MeiraGTx (NASDAQ:MGTX) had its price target raised by analysts at Piper Sandler from $28.00 to $30.00. They now have an "overweight" rating on the stock.
11/11
08:08 am
mgtx
MeiraGTx (NASDAQ:MGTX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $35.00 price target on the stock.
Medium
Report
MeiraGTx (NASDAQ:MGTX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $35.00 price target on the stock.
11/10
01:20 pm
mgtx
Eli Lilly keeps up ophthalmic gene therapy push with $475m MeiraGTx deal [Yahoo! Finance]
Low
Report
Eli Lilly keeps up ophthalmic gene therapy push with $475m MeiraGTx deal [Yahoo! Finance]
11/10
09:25 am
mgtx
Eli Lilly signs deal for MeiraGTx's gene therapy for severe eye disease [Yahoo! Finance Canada]
Medium
Report
Eli Lilly signs deal for MeiraGTx's gene therapy for severe eye disease [Yahoo! Finance Canada]
11/10
07:00 am
mgtx
MeiraGTx Enters into Strategic Collaboration with Eli Lilly and Company to Develop and Commercialize Genetic Medicines in Ophthalmology
High
Report
MeiraGTx Enters into Strategic Collaboration with Eli Lilly and Company to Develop and Commercialize Genetic Medicines in Ophthalmology
10/21
08:03 am
mgtx
MeiraGTx (NASDAQ:MGTX) is now covered by analysts at Raymond James Financial, Inc.. They set a "strong-buy" rating and a $29.00 price target on the stock.
Low
Report
MeiraGTx (NASDAQ:MGTX) is now covered by analysts at Raymond James Financial, Inc.. They set a "strong-buy" rating and a $29.00 price target on the stock.
10/7
08:38 am
mgtx
MeiraGTx Announces Two Posters at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress [Yahoo! Finance]
Low
Report
MeiraGTx Announces Two Posters at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress [Yahoo! Finance]
10/7
08:00 am
mgtx
MeiraGTx Announces Two Posters at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress
Low
Report
MeiraGTx Announces Two Posters at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress
8/15
08:22 am
mgtx
MeiraGTx Holdings PLC (NASDAQ: MGTX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $35.00 price target on the stock.
Medium
Report
MeiraGTx Holdings PLC (NASDAQ: MGTX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $35.00 price target on the stock.